{"disease":{"id":"cancer-of-the-esophagus","name":"cancer of the esophagus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05688761","title":"Nordic Gastric and Esophageal Tumor Study","phase":"","overall_status":"COMPLETED","enrollment_count":900000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04907643","title":"Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes","phase":"NA","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT06161818","title":"Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":216,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT03096054","title":"A CR-UK Phase I Trial of LY3143921","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":69,"lead_sponsor_name":"Cancer Research UK","has_results":false},{"nct_id":"NCT03482791","title":"Proton Beam Therapy in the Treatment of Esophageal Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT02642809","title":"Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04713891","title":"A Study of KF-0210 in Advanced Solid Tumors Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Keythera Pharmaceuticals (Australia) Pty Ltd","has_results":false},{"nct_id":"NCT04046575","title":"Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03108885","title":"Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence","phase":"","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04272268","title":"Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University Hospitals of North Midlands NHS Trust","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}